Skip to main content

DarioHealth Corp.

DRIO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001533998

In the last 90 days, DarioHealth Corp. insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $5.65M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding DarioHealth Corp. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of DRIO: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders39133−5
Shares8.19M105.6K8.02M−62.3K (−0.8%)
Value$9.75M$125.7K$8.98M−$646.8K (−6.7%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held DarioHealth Corp. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to DRIO in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.114,229$127.9K0.00%
Colony Group, LLC24,048$26.9K0.00%
Whittier Trust Co1,500$1.67K0.00%

Sold out (8)

Institutions that held DarioHealth Corp. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of DRIO in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Goldman Sachs Group Inc105,768$125.9K
Morgan Stanley100,817$120.0K
Susquehanna International Group, LLP38,394$45.7K
Allred Capital Management, LLC21,157$25.2K
Virtu Financial LLC11,803$14.0K
Cedar Wealth Management, LLC2,850$3.39K
Qube Research & Technologies Ltd4$4
FMR LLC1$1

Not filed for Q3 2024 yet (1)

Institutions that held DarioHealth Corp. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DRIO in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.105,619$125.7K